Ultragenyx
RARE
$43.85
Share price
-0.97%
Change (1 day)
0.55%
Change (1 year)
Categories
Market capitalization of Ultragenyx (RARE)
Market cap: $3.61 Billion
As of April 2024 Ultragenyx has a market cap of $3.61 Billion. This makes Ultragenyx the world's 3127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ultragenyx from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.61 B | -8.05% |
| 2023 | $3.92 B | 20.9% |
| 2022 | $3.24 B | -43.33% |
| 2021 | $5.73 B | -37.41% |
| 2020 | $9.15 B | 270.73% |
| 2019 | $2.47 B | 11.71% |
| 2018 | $2.21 B | 11.95% |
| 2017 | $1.97 B | -31.24% |
| 2016 | $2.87 B | -34.14% |
| 2015 | $4.36 B | 211.27% |
| 2014 | $1.40 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Ultragenyx was reported to be:
$3.64 Billion
$3.64 Billion
$3.64 Billion
$3.64 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.37 B | -89.50% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.37 B | -89.56% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $3.00 B | -16.80% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.59 B | 331.91% | 🇺🇸 USA |